These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24993815)

  • 1. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
    Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
    BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
    El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM
    Virol J; 2013 Jun; 10():199. PubMed ID: 23782993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.
    El-Fakharany EM; Abedelbaky N; Haroun BM; Sánchez L; Redwan NA; Redwan EM
    Virol J; 2012 Sep; 9():201. PubMed ID: 22978304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
    Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
    J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
    Redwan el-RM; Tabll A
    J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
    Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
    Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role.
    Khan JA; Kumar P; Paramasivam M; Yadav RS; Sahani MS; Sharma S; Srinivasan A; Singh TP
    J Mol Biol; 2001 Jun; 309(3):751-61. PubMed ID: 11397094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
    Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
    J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
    Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
    Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
    Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
    Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
    Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antimicrobial Bifunctional Camel Lactoferrin: In Silico and Molecular Dynamic Perspective.
    Alhumam MN; Alhumam N; Kandeel M
    Biomed Res Int; 2023; 2023():2322286. PubMed ID: 37260852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection.
    Pietrantoni A; Ammendolia MG; Tinari A; Siciliano R; Valenti P; Superti F
    Antiviral Res; 2006 Feb; 69(2):98-106. PubMed ID: 16386316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
    Di Biase AM; Pietrantoni A; Tinari A; Siciliano R; Valenti P; Antonini G; Seganti L; Superti F
    J Med Virol; 2003 Apr; 69(4):495-502. PubMed ID: 12601757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides.
    Berkhout B; van Wamel JL; Beljaars L; Meijer DK; Visser S; Floris R
    Antiviral Res; 2002 Aug; 55(2):341-55. PubMed ID: 12103434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.
    Nozaki A; Ikeda M; Naganuma A; Nakamura T; Inudoh M; Tanaka K; Kato N
    J Biol Chem; 2003 Mar; 278(12):10162-73. PubMed ID: 12522210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities of lactoferrin.
    van der Strate BW; Beljaars L; Molema G; Harmsen MC; Meijer DK
    Antiviral Res; 2001 Dec; 52(3):225-39. PubMed ID: 11675140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.
    Almehdar HA; El-Baky NA; Alhaider AA; Almuhaideb SA; Alhaider AA; Albiheyri RS; Uversky VN; Redwan EM
    Protein J; 2019 Aug; 38(4):479-496. PubMed ID: 30963371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
    Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
    Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
    Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
    Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.